{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T22:50:48Z","timestamp":1775343048480,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Clinical research has shown that chronic antipsychotic drug (APD) treatment further decreases cortical gray matter and hippocampus volume, and increases striatal and ventricular volume in patients with schizophrenia. D2-like receptor blockade is necessary for clinical efficacy of the drugs, and may be responsible for inducing these volume changes. However, the role of other D2-like receptors, such as D3, remains unclear. Following our previous work, we undertook a longitudinal study to examine the effects of chronic (9-week) typical (haloperidol (HAL)) and atypical (clozapine (CLZ)) APDs on the neuroanatomy of wild-type (WT) and dopamine D3-knockout (D3KO) mice using magnetic resonance imaging (MRI) and histological assessments in a sub-region of the anterior cingulate cortex (the prelimbic [PL] area) and striatum. D3KO mice had larger striatal volume prior to APD administration, coupled with increased glial and neuronal cell density. Chronic HAL administration increased striatal volume in both WT and D3KO mice, and reduced PL area volume in D3KO mice both at trend level. CLZ increased volume of the PL area of WT mice at trend level, but decreased D3KO PL area glial cell density. Both typical and atypical APD administration induced neuroanatomical remodeling of regions rich in D3 receptor expression, and typically altered in schizophrenia. Our findings provide novel insights on the role of D3 receptors in structural changes observed following APD administration in clinical populations.<\/jats:p>","DOI":"10.1038\/s41598-019-43955-4","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T10:03:50Z","timestamp":1558692230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Role of D3 dopamine receptors in modulating neuroanatomical changes in response to antipsychotic administration"],"prefix":"10.1038","volume":"9","author":[{"given":"Elisa","family":"Guma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Rocchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7766-1187","authenticated-orcid":false,"given":"Gabriel A.","family":"Devenyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Tanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel P.","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason P.","family":"Lerch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Elgbeili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blandine","family":"Courcot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naguib","family":"Mechawar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Mallar","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5876-9822","authenticated-orcid":false,"given":"Bruno","family":"Giros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,24]]},"reference":[{"key":"43955_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/347146a0","volume":"347","author":"P Sokoloff","year":"1990","unstructured":"Sokoloff, P., Giros, B., Martres, M. P., Bouthenet, M. L. & Schwartz, J. C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347, 146\u2013151 (1990).","journal-title":"Nature"},{"key":"43955_CR2","first-page":"501","volume":"311","author":"B Giros","year":"1990","unstructured":"Giros, B., Martres, M. P., Sokoloff, P. & Schwartz, J. C. CDNA cloning of the human dopaminergic D3 receptor and chromosomes identification. CR Acad Sci Paris 311, 501\u2013508 (1990).","journal-title":"CR Acad Sci Paris"},{"key":"43955_CR3","doi-asserted-by":"crossref","unstructured":"Gross, G. & Drescher, K. The role of dopamine D(3) receptors in antipsychotic activity and cognitive functions. Handb. Exp. Pharmacol. 167\u2013210 (2012).","DOI":"10.1007\/978-3-642-25758-2_7"},{"key":"43955_CR4","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/npp.2011.254","volume":"37","author":"DJG Watson","year":"2012","unstructured":"Watson, D. J. G. et al. Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: a key role for the prefrontal cortex. Neuropsychopharmacology 37, 770\u2013786 (2012).","journal-title":"Neuropsychopharmacology"},{"key":"43955_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00210-012-0806-3","volume":"386","author":"G Gross","year":"2013","unstructured":"Gross, G., Wicke, K. & Drescher, K. U. Dopamine D3 receptor antagonism\u2014still a therapeutic option for the treatment of schizophrenia. Naunyn. Schmiedebergs. Arch. Pharmacol. 386, 155\u2013166 (2013).","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"43955_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","volume":"68","author":"B-C Ho","year":"2011","unstructured":"Ho, B.-C., Andreasen, N. C., Ziebell, S., Pierson, R. & Magnotta, V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch. Gen. Psychiatry 68, 128\u2013137 (2011).","journal-title":"Arch. Gen. Psychiatry"},{"key":"43955_CR7","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1017\/S0033291709005315","volume":"39","author":"S Navari","year":"2009","unstructured":"Navari, S. & Dazzan, P. Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol. Med. 39, 1763\u20131777 (2009).","journal-title":"Psychol. Med."},{"key":"43955_CR8","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.neubiorev.2013.06.001","volume":"37","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli, P. et al. Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci. Biobehav. Rev. 37, 1680\u20131691 (2013).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"43955_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S0140-6736(95)90441-7","volume":"345","author":"MH Chakos","year":"1995","unstructured":"Chakos, M. H., Lieberman, J. A., Alvir, J., Bilder, R. & Ashtari, M. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. Lancet 345, 456\u2013457 (1995).","journal-title":"Lancet"},{"key":"43955_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0920-9964(97)82479-6","volume":"24","author":"S Kapur","year":"1997","unstructured":"Kapur, S., Remington, G., Jones, C., Houle, S. & Zipursky, R. 471 - \u2018Typical\u2019 vs. \u2018Atypical\u2019: Lessons from pet studies of 5-HT2 and D2 occupancy of antipsychotics. Schizophr. Res. 24, 167 (1997).","journal-title":"Schizophr. Res."},{"key":"43955_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.pscychresns.2006.10.002","volume":"154","author":"A Glenthoj","year":"2007","unstructured":"Glenthoj, A. et al. Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug. Psychiatry Res. 154, 199\u2013208 (2007).","journal-title":"Psychiatry Res."},{"key":"43955_CR12","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.biopsych.2013.09.012","volume":"75","author":"AC Vernon","year":"2014","unstructured":"Vernon, A. C. et al. Reduced cortical volume and elevated astrocyte density in rats chronically treated with antipsychotic drugs-linking magnetic resonance imaging findings to cellular pathology. Biol. Psychiatry 75, 982\u2013990 (2014).","journal-title":"Biol. Psychiatry"},{"key":"43955_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0893-133X(02)00287-7","volume":"27","author":"C Andersson","year":"2002","unstructured":"Andersson, C., Hamer, R. M., Lawler, C. P., Mailman, R. B. & Lieberman, J. A. Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs. Neuropsychopharmacology 27, 143\u2013151 (2002).","journal-title":"Neuropsychopharmacology"},{"key":"43955_CR14","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/sj.npp.1300710","volume":"30","author":"K-A Dorph-Petersen","year":"2005","unstructured":"Dorph-Petersen, K.-A. et al. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30, 1649\u20131661 (2005).","journal-title":"Neuropsychopharmacology"},{"key":"43955_CR15","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.biopsych.2010.11.010","volume":"69","author":"AC Vernon","year":"2011","unstructured":"Vernon, A. C., Natesan, S., Modo, M. & Kapur, S. Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation. Biol. Psychiatry 69, 936\u2013944 (2011).","journal-title":"Biol. Psychiatry"},{"key":"43955_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.biopsych.2011.12.004","volume":"71","author":"AC Vernon","year":"2012","unstructured":"Vernon, A. C. et al. Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation. Biol. Psychiatry 71, 855\u2013863 (2012).","journal-title":"Biol. Psychiatry"},{"key":"43955_CR17","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1017\/S0033291716001768","volume":"46","author":"WR Crum","year":"2016","unstructured":"Crum, W. R. et al. Chronic exposure to haloperidol and olanzapine leads to common and divergent shape changes in the rat hippocampus in the absence of grey-matter volume loss. Psychol. Med. 46, 3081\u20133093 (2016).","journal-title":"Psychol. Med."},{"key":"43955_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neuroimage.2018.04.054","volume":"176","author":"E Guma","year":"2018","unstructured":"Guma, E. et al. Regional brain volume changes following chronic antipsychotic administration are mediated by the dopamine D2 receptor. Neuroimage 176, 226\u2013238 (2018).","journal-title":"Neuroimage"},{"key":"43955_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/pr.110.002642","volume":"63","author":"J-M Beaulieu","year":"2011","unstructured":"Beaulieu, J.-M. & Gainetdinov, R. R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 63, 182\u2013217 (2011).","journal-title":"Pharmacol. Rev."},{"key":"43955_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0169-328X(95)00112-6","volume":"33","author":"NM Richtand","year":"1995","unstructured":"Richtand, N. M., Kelsoe, J. R., Segal, D. S. & Kuczenski, R. Regional quantification of D1, D2, and D3 dopamine receptor mRNA in rat brain using a ribonuclease protection assay. Brain Res. Mol. Brain Res. 33, 97\u2013103 (1995).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"43955_CR21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.biopsych.2007.08.018","volume":"63","author":"GT Konopaske","year":"2008","unstructured":"Konopaske, G. T. et al. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol. Psychiatry 63, 759\u2013765 (2008).","journal-title":"Biol. Psychiatry"},{"key":"43955_CR22","first-page":"119","volume":"53","author":"PG Strange","year":"2001","unstructured":"Strange, P. G. Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects. Pharmacol. Rev. 53, 119\u2013133 (2001).","journal-title":"Pharmacol. Rev."},{"key":"43955_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","volume":"78","author":"C Missale","year":"1998","unstructured":"Missale, C., Nash, S. R., Robinson, S. W., Jaber, M. & Caron, M. G. Dopamine receptors: from structure to function. Physiol. Rev. 78, 189\u2013225 (1998).","journal-title":"Physiol. Rev."},{"key":"43955_CR24","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929\u201311947 (2014).","journal-title":"J. Neurosci."},{"key":"43955_CR25","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.euroneuro.2015.08.004","volume":"25","author":"M-C Cotel","year":"2015","unstructured":"Cotel, M.-C. et al. Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses. Eur. Neuropsychopharmacol. 25, 2098\u20132107 (2015).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"43955_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/cercor\/6.4.561","volume":"6","author":"KM Merchant","year":"1996","unstructured":"Merchant, K. M., Figur, L. M. & Evans, D. L. Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs: role of dopamine D2 and D3 receptors. Cereb. Cortex 6, 561\u2013570 (1996).","journal-title":"Cereb. Cortex"},{"key":"43955_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41386-018-0143-4","volume":"44","author":"M Revenga","year":"2019","unstructured":"Revenga, M. et al. Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity. Neuropsychopharmacology 44, 443\u2013454 (2019).","journal-title":"Neuropsychopharmacology"},{"key":"43955_CR28","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1073\/pnas.93.5.1945","volume":"93","author":"D Accili","year":"1996","unstructured":"Accili, D. et al. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc. Natl. Acad. Sci. USA 93, 1945\u20131949 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"43955_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0163-7258(01)00145-0","volume":"91","author":"SB Glickstein","year":"2001","unstructured":"Glickstein, S. B. & Schmauss, C. Dopamine receptor functions: lessions from knockout mice. Pharmacol. Ther. 91, 63\u201383 (2001).","journal-title":"Pharmacol. Ther."},{"key":"43955_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1124\/jpet.102.046987","volume":"305","author":"S Kapur","year":"2003","unstructured":"Kapur, S., VanderSpek, S. C., Brownlee, B. A. & Nobrega, J. N. Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J. Pharmacol. Exp. Ther. 305, 625\u2013631 (2003).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"43955_CR31","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/archpsyc.57.6.553","volume":"57","author":"S Kapur","year":"2000","unstructured":"Kapur, S. et al. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Arch. Gen. Psychiatry 57, 553\u2013559 (2000).","journal-title":"Arch. Gen. Psychiatry"},{"key":"43955_CR32","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/sj.npp.1300233","volume":"28","author":"P Turrone","year":"2003","unstructured":"Turrone, P., Remington, G., Kapur, S. & Nobrega, J. N. Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats. Neuropsychopharmacology 28, 1433\u20131439 (2003).","journal-title":"Neuropsychopharmacology"},{"key":"43955_CR33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0149-7634(02)00008-8","volume":"26","author":"P Turrone","year":"2002","unstructured":"Turrone, P., Remington, G. & Nobrega, J. N. The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D2 receptor occupancy? Neurosci. Biobehav. Rev. 26, 361\u2013380 (2002).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"43955_CR34","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/schbul\/sbq083","volume":"36","author":"G Remington","year":"2010","unstructured":"Remington, G. & Kapur, S. Antipsychotic dosing: how much but also how often? Schizophr. Bull. 36, 900\u2013903 (2010).","journal-title":"Schizophr. Bull."},{"key":"43955_CR35","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1038\/npp.2014.152","volume":"39","author":"S D\u00fcring","year":"2014","unstructured":"D\u00fcring, S., Glenth\u00f8j, B. Y., Andersen, G. S. & Oranje, B. Effects of dopamine D2\/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patients. Neuropsychopharmacology 39, 3000\u20133008 (2014).","journal-title":"Neuropsychopharmacology"},{"key":"43955_CR36","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1007\/s00213-016-4382-y","volume":"233","author":"RR Girgis","year":"2016","unstructured":"Girgis, R. R. et al. Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3\/D2 receptor ligand [11C]-(+)-PHNO. Psychopharmacology 233, 3503\u20133512 (2016).","journal-title":"Psychopharmacology"},{"key":"43955_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.schres.2011.05.005","volume":"131","author":"R Mizrahi","year":"2011","unstructured":"Mizrahi, R. et al. Effects of antipsychotics on D3 receptors: A clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO. Schizophr. Res. 131, 63\u201368 (2011).","journal-title":"Schizophr. Res."},{"key":"43955_CR38","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1523\/JNEUROSCI.0310-17.2017","volume":"37","author":"RL Clarkson","year":"2017","unstructured":"Clarkson, R. L., Liptak, A. T., Gee, S. M., Sohal, V. S. & Bender, K. J. D3 Receptors Regulate Excitability in a Unique Class of Prefrontal Pyramidal Cells. J. Neurosci. 37, 5846\u20135860 (2017).","journal-title":"J. Neurosci."},{"key":"43955_CR39","unstructured":"Clarkson, R. L. Dopamine D3 Receptor Modulation of Prefrontal Cells and Circuits. (University of California, San Francisco 2017)."},{"key":"43955_CR40","doi-asserted-by":"crossref","unstructured":"Gorgievski, V., Tzavara, E. T. & Giros, B. Study of Dopamine Receptor and Dopamine Transporter Networks in Mice. In Dopamine Receptor Technologies (ed. Tiberi, M.) 305\u2013328 (Springer New York 2015).","DOI":"10.1007\/978-1-4939-2196-6_17"},{"key":"43955_CR41","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1046\/j.1460-9568.2000.00063.x","volume":"12","author":"C Spielewoy","year":"2000","unstructured":"Spielewoy, C. et al. Increased rewarding properties of morphine in dopamine-transporter knockout mice. Eur. J. Neurosci. 12, 1827\u20131837 (2000).","journal-title":"Eur. J. Neurosci."},{"key":"43955_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.schres.2013.06.007","volume":"149","author":"KE Stevens","year":"2013","unstructured":"Stevens, K. E., Zheng, L. & Abrams, D. J. Intermittent versus continuous central administration of clozapine in DBA\/2 mice, improvement in sensory inhibition deficits. Schizophr. Res. 149, 121\u2013126 (2013).","journal-title":"Schizophr. Res."},{"key":"43955_CR43","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1006\/nimg.2002.1132","volume":"17","author":"M Jenkinson","year":"2002","unstructured":"Jenkinson, M., Bannister, P., Brady, M. & Smith, S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17, 825\u2013841 (2002).","journal-title":"Neuroimage"},{"key":"43955_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1361-8415(01)00036-6","volume":"5","author":"M Jenkinson","year":"2001","unstructured":"Jenkinson, M. & Smith, S. A global optimisation method for robust affine registration of brain images. Med. Image Anal. 5, 143\u2013156 (2001).","journal-title":"Med. Image Anal."},{"key":"43955_CR45","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1002\/hbm.22092","volume":"34","author":"MM Chakravarty","year":"2013","unstructured":"Chakravarty, M. M. et al. Performing label-fusion-based segmentation using multiple automatically generated templates. Hum. Brain Mapp. 34, 2635\u20132654 (2013).","journal-title":"Hum. Brain Mapp."},{"key":"43955_CR46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuroimage.2008.03.037","volume":"42","author":"AE Dorr","year":"2008","unstructured":"Dorr, A. E., Lerch, J. P., Spring, S., Kabani, N. & Henkelman, R. M. High resolution three-dimensional brain atlas using an average magnetic resonance image of 40 adult C57Bl\/6J mice. Neuroimage 42, 60\u201369 (2008).","journal-title":"Neuroimage"},{"key":"43955_CR47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/aur.1344","volume":"7","author":"PE Steadman","year":"2014","unstructured":"Steadman, P. E. et al. Genetic effects on cerebellar structure across mouse models of autism using a magnetic resonance imaging atlas. Autism Res. 7, 124\u2013137 (2014).","journal-title":"Autism Res."},{"key":"43955_CR48","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.neuroimage.2013.04.008","volume":"78","author":"JFP Ullmann","year":"2013","unstructured":"Ullmann, J. F. P., Watson, C., Janke, A. L., Kurniawan, N. D. & Reutens, D. C. A segmentation protocol and MRI atlas of the C57BL\/6J mouse neocortex. Neuroimage 78, 196\u2013203 (2013).","journal-title":"Neuroimage"},{"key":"43955_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.media.2007.06.004","volume":"12","author":"BB Avants","year":"2008","unstructured":"Avants, B. B., Epstein, C. L., Grossman, M. & Gee, J. C. Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med. Image Anal. 12, 26\u201341 (2008).","journal-title":"Med. Image Anal."},{"key":"43955_CR50","unstructured":"Franklin, K. B. & Paxinos, G. The Mouse Brain in Stereotaxic Coordinates, Compact. The Coronal Plates and Diagrams. (Amsterdam: Elsevier Academic Press 2008)."},{"key":"43955_CR51","doi-asserted-by":"publisher","first-page":"e38692","DOI":"10.1371\/journal.pone.0038692","volume":"7","author":"M Garc\u00eda-Amado","year":"2012","unstructured":"Garc\u00eda-Amado, M. & Prensa, L. Stereological analysis of neuron, glial and endothelial cell numbers in the human amygdaloid complex. PLoS One 7, e38692 (2012).","journal-title":"PLoS One"},{"key":"43955_CR52","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1002\/cne.23101","volume":"520","author":"EL Giannaris","year":"2012","unstructured":"Giannaris, E. L. & Rosene, D. L. A stereological study of the numbers of neurons and glia in the primary visual cortex across the lifespan of male and female rhesus monkeys. J. Comp. Neurol. 520, 3492\u20133508 (2012).","journal-title":"J. Comp. Neurol."},{"key":"43955_CR53","unstructured":"Pinheiro, J., Bates, D., DebRoy, S. & Sarkar, D. R Development Core Team. 2010. nlme: Linear and nonlinear mixed effects models. R package version, Vol. 3. Vienna: The R Project for Statistical Computing (2007)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43955-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43955-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43955-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:51:02Z","timestamp":1671270662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43955-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,24]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["43955"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-43955-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,24]]},"assertion":[{"value":"9 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None of the authors of this manuscript have any competing interests. This disclosure includes direct or indirect financial and non-financial interests or personal relationships, interests, and affiliations relevant to the subject matter of the manuscript that have occurred over the last two years, or that are expected in the foreseeable future. This disclosure includes, but is not limited to, grants or funding, employment, affiliations, patents (in preparation, filed, or granted), inventions, honoraria, consultancies, royalties, stock options\/ownership, or expert testimony.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7850"}}